For a description of the Company’s share‑based compensation plans, including equity plan structure and Restricted Stock Units (“RSUs”) program mechanics, refer to Note 17 to the Consolidated Financial Statements in the 2025 Form 10‑K.

Activity in the Company’s stock option plans is summarized in the following table:


	Shares			Weighted Average Price		Weighted Average Remaining (Yrs.)		Aggregate Intrinsic (000’s)
Outstanding at January 1, 2026		28,815		$	61.00
Exercised		(10,104	)		67.04
Expired		(307	)		43.97
Outstanding at September 30,2026		18,404			57.97		0.72	$	765
Exercisable at September 30,2026		18,404			57.97		0.72	$	765

Outstanding RSUs for the nine months ended September 30, 2026, are summarized in the following table:


Restricted Stock Units	Shares			Weighted- Average Grant-Date Fair Value
Outstanding at January 1, 2026		820,878		$	86.43
Granted		454,530			93.90
Vested		(408,581	)		80.28
Forfeited		(13,012	)		91.58
Outstanding at September 30,2026		853,815		$	93.27

If maximum performance is achieved pursuant to the 2024, 2025 and 2026 Long Term Incentive performance-based RSU grants, an additional 133,514 shares in total may be issued by the Company at the end of the three-year performance periods.

As of September 30, 2026, there was $40.8 million of total unrecognized compensation cost at target related to nonvested RSUs granted under the plan. This cost is expected to be recognized over a weighted-average period of 1.25 years as of September 30, 2026. The total fair value of RSUs vested and released during the nine months ended September 30, 2026, was $41.8 million.